Q: CATX I couldn't find this in your database and would love your analysis of this small cap American company in Seattle?
Thanx as usual
Gary
Thanx as usual
Gary
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
-
Merck & Company Inc. (MRK $99.72)
-
Pfizer Inc. (PFE $26.03)
-
GSK plc American Depositary Shares (Each representing two) (GSK $48.41)
-
Dynavax Technologies Corporation (DVAX $10.89)
Q: I understand there has been some type of study which shows people who have taken the Shingles vaccine are less likely to develop Alzheimer’s like diseases. The scientific community seems not to know why this is so. There are a lot of unknowns on this study to say the least. Do you know any first rate Pharma companies that are leaders in the development and manufacturing the Shingles vaccines? I know there are a number of Shingles vaccines out in the marketplace, probably made by different companies. Does Bloomberg have anything to say on the subject? Any thoughts you have would be appreciated.
Jim
Jim
Q: MCK has had significant declines in the last several days. Fortunately , I got out before there was too much damage and I am wondering at what price I should get back in? What is the reason for the drop?
Many thanks for your thoughts.
Ian
Many thanks for your thoughts.
Ian
Q: Healthcare hasn’t done very much but I don’t have any in my portfolio. What etf would you recommend . Greetings Peter.
Q: What's the best way to play the GLP-1/Semaglutide bandwagon now that the WHO is encouraging its use as a way to better health through weight loss?
Q: Better buy right now. HIMS or HROW? Thank you
Q: Is ibrx a reasonable company to make a small investment in?
Its treatment anktiva is approved for some cancers already and appears to have broader applications. The patents seem to have about 10 years to run.
Thank you for your research and opinion.
Its treatment anktiva is approved for some cancers already and appears to have broader applications. The patents seem to have about 10 years to run.
Thank you for your research and opinion.
Q: trying to decide between these two companies. PG does seem to have negative momentum. Is there more upside in PG or do you prefer JNJ or equal amounts of both?
Thanks Dave
Thanks Dave
Q: Hi Peter,
I have a question on Well Health and their Competition Bureau issue. Would it not be bullish for a company of Well's size to be considered to have a competitive edge on Telus, Loblaws et al considering it only has about 2% of the Primary Care clinics in Canada. I am wondering if this is an opportunity especially during tax loss.
I have a question on Well Health and their Competition Bureau issue. Would it not be bullish for a company of Well's size to be considered to have a competitive edge on Telus, Loblaws et al considering it only has about 2% of the Primary Care clinics in Canada. I am wondering if this is an opportunity especially during tax loss.
Q: XLV had a good run. Would you buy it here or wait for a pull back, Do you think that the healthcare sector has more momentum to the upside?
Thank. Cheers
Thank. Cheers
Q: Recent news shows WELL is going through court case. Can you explain what it is all about, likely out come and impact on share price.
-
WELL Health Technologies Corp. (WELL $3.96)
-
HealWELL AI Inc. Class A Subordinate Voting Shares (AIDX $0.94)
Q: Hello,
What is your analysis of the Competition Bureau investigation and what risks does it pose to Well's future performance?
Thanks
What is your analysis of the Competition Bureau investigation and what risks does it pose to Well's future performance?
Thanks
-
HealWELL AI Inc. Class A Subordinate Voting Shares (AIDX $0.94)
-
Westgold Resources Limited Ordinary shares (WGX $5.33)
Q: Hi there, can AIDX be considered dead on arrival now, for its IPO possibility next year?
The share price action has brought it down considerably during this tax loss selling season!
Where do you see support for the shares now?
Do you consider the shares priced fairly here at 1.00?
Current growth and outlook looks good, share price not so much, horrible!
I believe my question on WGX last week has gone MIA...your thoughts on their last quarter please?
Thanks!
The share price action has brought it down considerably during this tax loss selling season!
Where do you see support for the shares now?
Do you consider the shares priced fairly here at 1.00?
Current growth and outlook looks good, share price not so much, horrible!
I believe my question on WGX last week has gone MIA...your thoughts on their last quarter please?
Thanks!
Q: Have been following this interesting stock for a while now and would love a breakdown of it's merits and outlook and would you recommend a small position?
Q: Has NVO fallen to a level you see as attractive?
Q: Do you recommend moving on at this point given the buyout by Abbott? Would you consider waiting it out until 2026 to defer taxes?
Q: I’m considering selling WELL for a tax loss. And buying VHI as replacement for at least few months. Thoughts please?
Q: I first bought this in 2020, have added a few times and currently have not made a dollar. 5 years is a lot of 'wait time'. How much longer do I give this?
C.
C.
Q: Hello 5i
I realize it is very early in its public life but please tell me what you can about BLLN.
Thank you
Dave
I realize it is very early in its public life but please tell me what you can about BLLN.
Thank you
Dave
Q: What can you see for this little bio tech companies future Sellas life Sciences group. Their approach to cancer treatment or cures seems interesting but what does the business side look like.
Thanks
Thanks